MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Second Sight Medical Products EV/EBITDA Ratio 2011-2026 | EYES
Annual EV/EBITDA Ratio Second Sight Medical Products
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 3.87 | -3.48 | 0.0567 | -1.44 | -3.63 | -1.66 | -9.09 | -11.4 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.87 | -11.4 | -3.35 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Butterfly Network
BFLY
|
-3.9 | $ 4.22 | 0.84 % | $ 893 M |  USA |
 |
Delcath Systems
DCTH
|
-1.69 | $ 8.94 | -1.81 % | $ 320 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M |  China |
 |
FONAR Corporation
FONR
|
-33.4 | $ 18.34 | 0.01 % | $ 120 M | USA |
 |
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-0.915 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | USA |
 |
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | USA |
 |
Inogen
INGN
|
17.4 | $ 6.32 | -2.02 % | $ 168 M | USA |
 |
IRadimed Corporation
IRMD
|
46 | $ 99.22 | 0.02 % | $ 1.26 B | USA |
 |
LivaNova PLC
LIVN
|
215 | $ 63.34 | 0.16 % | $ 3.46 B |  Britain |
 |
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | USA |
 |
LENSAR
LNSR
|
-1.48 | $ 5.71 | -5.93 % | $ 65.8 M | USA |
 |
Medtronic PLC
MDT
|
24.4 | $ 86.81 | -0.41 % | $ 112 B | USA |
 |
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.35 | -0.04 % | $ 21.8 M | USA |
 |
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | USA |
 |
Insulet Corporation
PODD
|
95.3 | $ 225.4 | -0.74 % | $ 15.9 B | USA |
 |
AxoGen
AXGN
|
-19.1 | $ 32.32 | 1.8 % | $ 1.49 B | USA |
 |
Profound Medical Corp.
PROF
|
-7.43 | $ 5.16 | -4.36 % | $ 180 M |  Canada |
 |
CONMED Corporation
CNMD
|
40.2 | $ 36.49 | -0.37 % | $ 1.13 B | USA |
 |
Orthofix Medical
OFIX
|
31.1 | $ 11.76 | -0.93 % | $ 466 M |  Curacao |
 |
Quanterix Corporation
QTRX
|
-14.7 | $ 3.66 | -7.23 % | $ 156 M | USA |
 |
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Electromed
ELMD
|
26.4 | $ 24.64 | 0.61 % | $ 208 M | USA |
 |
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M | Canada |
 |
Sintx Technologies
SINT
|
0.974 | $ 2.58 | 1.12 % | $ 7.16 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.72 | 6.28 % | $ 39.2 M | USA |
 |
Aethlon Medical
AEMD
|
-0.459 | $ 2.15 | -6.52 % | $ 3.36 M | USA |
 |
Sensus Healthcare
SRTS
|
22.6 | $ 4.0 | -2.68 % | $ 65.3 M | USA |
 |
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | USA |
 |
Stryker Corporation
SYK
|
30 | $ 328.28 | -1.3 % | $ 125 B | USA |
 |
Tactile Systems Technology
TCMD
|
241 | $ 26.48 | -0.13 % | $ 606 M | USA |
 |
AdaptHealth Corp.
AHCO
|
11 | $ 11.25 | 8.49 % | $ 1.52 B | USA |
 |
Myomo
MYO
|
-2.96 | $ 0.69 | -2.14 % | $ 28.9 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-0.00869 | $ 2.34 | -4.1 % | $ 137 M | Israel |
 |
Invacare Corporation
IVC
|
1.89 | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
730 | $ 3.85 | 3.08 % | $ 144 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
-165 | $ 15.9 | -3.46 % | $ 373 M | USA |
 |
Penumbra
PEN
|
938 | $ 334.59 | -0.29 % | $ 13 B | USA |